Trump’s address to Congress to shine some light on La La Land

Published 28-FEB-2017 09:01 A.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

There was an air of uncertainty surrounding US markets on the eve of President Trump delivering his address to Congress which should incorporate commentary on issues such as infrastructure planning, tax reform, and regulatory changes in the financial industry.

Delivering on the key issues that have driven the substantial and sustained run in equities will be crucial in terms of maintaining market equilibrium. While good news appears to be factored in, suggesting little likelihood of a continued substantial run in equities markets, should Trump not deliver what the market is expecting the retracement could be severe.

This should be the first real litmus test for Americans to decide whether they really are ‘winning’ under a Trump administration or whether they have just been living in La La Land emboldened with confidence by a figurehead moonlighting as the US president, one who often sounds very similar to the celebrity in the following clip.

With uncertainty prevailing, the Dow spent the majority of the day in negative territory, and finished broadly in line with the previous day’s close of 20,821 points

Key movers were in the defence contracting sector after Trump said his first budget would include a 10% increase in military spending. Lockheed Martin gained more than 2% and Boeing Co was up approximately 1.3% as markets drew to a close

The NASDAQ ran strongly in afternoon trading, finishing up 0.2% at 5858 points.

Fluctuations in the gold price throughout the day’s trading reflected the mood on Wall Street. The precious metal traded as high as US$1265 per ounce until midday, but as the Dow and the NASDAQ staged a recovery it retraced to close at $1255 per ounce, down slightly on the previous day’s close.

UK and European markets were also flat with the FTSE 100 closing at 7253 points, representing an increase of 0.1%.

In mainland Europe the DAX gained nearly 0.2% to close at 11,822 points, while the Paris CAC 40 finished in line with the previous day’s close.

On the commodities front, oil flatlined finishing in the vicinity of circa US$54 per barrel.

Iron ore was the main mover as it rallied 2% to finish at US$92.33 per tonne.

Nickel was the pick of the base metals as it gained 1.8% to finish at US$4.98 per pound, inching closer to the recent two month high of US$5.02 per pound.

Elsewhere, copper and lead were relatively flat while zinc came off nearly 1%.

The Australian dollar finished at US$0.768.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free